NT Mobile Menu

Search form


AAN 2015

AAN 2015

The 67th Annual Meeting of the American Academy of Neurology took place April 18-25 at the Walter E. Washington Convention Center in Washington, DC. You'll find highlights from the conference here.

AAN 2015

New drugs for Alzheimer disease

These two new drugs for Alzheimer disease, presented at AAN 2015, are too good not to review. Here, a 6-slide summary of aducanumab and encenicline studies.

Is fatigue with MS related to diet? Is alcohol intake tied to lower MS disability and severity? Researchers at AAN 2015 reported on how patients are affected by what they eat and drink.

PACAP38 is a potent aggravator of migraine, a new study shows. This provides several new potential therapeutic targets -- most prominently a specific PACAP receptor PAC1.


Intriguing research is helping to shape our understanding of the functional connectivity and brain structure of migraineurs.

©Shane Maritch/Shutterstock.com

Worse strokes are more likely to occur in patients who are resistant to aspirin. Better ways to identify those patients are needed.

Here's a handy synopsis of a “hands-on” review of the current state of monitoring disease and treatment decision making in patients with multiple sclerosis.

This new guideline could change the approach many physicians take to treating a first seizure--and could improve patients’ lives.


Subscribe to AAN 2015 on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.